Compare Brigit Biofarmaka Teknologi Tbk. (OBAT) vs Teknologi Karya Digital Nusa Tbk. (TRON) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brigit Biofarmaka Teknologi Tbk. vs Teknologi Karya Digital Nusa Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 43.9K 24h volume), while Teknologi Karya Digital Nusa Tbk. trades at Rp101 (market cap 298.08B, 2.3M 24h volume). The key difference: Teknologi Karya Digital Nusa Tbk. is the larger of the two by market cap, and Teknologi Karya Digital Nusa Tbk. is more actively traded (2.3M versus 43.9K). Which is the better fit depends on your goals.
| OBAT | TRON | |
|---|---|---|
Market Cap | 164.65B | 298.08B |
Volume | 43.9K | 2.3M |
Lot | 439 | 22.95K |
Turnover | 10.6M | 230.36M |
Average Price | 241.43 | 100.37 |
Value | 10.6M | 230.36M |
Indicative Equilibrium Price | 238 | 102 |
Indicative Equilibrium Volume | 100 | 29 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →About Teknologi Karya Digital Nusa Tbk.
PT Teknologi Karya Digital Nusa Tbk (formerly PT Damai Harapan Sentosa) (the Entity) wasestablished based on Notarial Deed No. 25 dated January 7, 2011 of Tjoa Karina Juwita SH., Notaryin Jakarta. The Entity started its commercial operations in 2015. PT Teknologi Karya Digital Nusa Tbk is the parent entity, whereas David Santoso is the ultimate beneficial owner starting from 2020.
Read more on TRON →
